100 Participants Needed

Virtual Self-Management Program for Juvenile Arthritis

HS
JB
Overseen ByJessica Booth, BSc
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Calgary
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The aim of this project is to conduct a pilot randomized controlled trial (RCT) to evaluate the feasibility and preliminary effectiveness of a virtual group based self-management program (SMP) in adolescents with JIA across different provinces compared to a wait-list control group receiving only standard of care. Participants in the SMP group will partake in four 60-90 minute group sessions conducted over 8 weeks. The intervention is a multifaceted program that includes JIA disease education, self-management strategies, and peer support. Both the interventional and control group will be asked to complete baseline and post-test measures. Participants in the control group will be offered the SMP after completion of the post-control outcome measures.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on a self-management program rather than medication changes.

What data supports the effectiveness of the treatment Virtual Self-Management Program for Juvenile Arthritis?

Research shows that self-management programs, including internet-based ones, can improve health behaviors and outcomes for arthritis patients. Additionally, eHealth and mobile health interventions have been found to be effective in supporting the management of Juvenile Idiopathic Arthritis.12345

Is the Virtual Self-Management Program for Juvenile Arthritis safe for humans?

The available research does not specifically address safety concerns, but self-management programs for juvenile arthritis, including virtual ones, are generally focused on providing information and support, which are typically safe for participants.12356

How is the Virtual Self-Management Program for Juvenile Arthritis different from other treatments?

The Virtual Self-Management Program for Juvenile Arthritis is unique because it focuses on empowering young patients to manage their condition through online resources, providing disease information, self-management strategies, and social support, which is different from traditional treatments that often rely heavily on medication and in-person care.12347

Eligibility Criteria

This trial is for adolescents with Juvenile Idiopathic Arthritis (JIA) who are interested in a virtual program to help manage their condition. Participants should be willing to attend online group sessions and complete certain health measures before and after the program.

Inclusion Criteria

I am between 12 and 17 years old.
Willing and able to complete online measures
Followed in one of the pediatric rheumatology clinics participating in the RCT
See 2 more

Exclusion Criteria

I have other chronic conditions that could affect my treatment results.
I do not have untreated mental health issues that prevent me from understanding or participating in group activities.
Past participation in the last year or participating in another peer-support or self-management program
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants in the SMP group partake in four 60-90 minute virtual group sessions over 8 weeks, including JIA disease education, self-management strategies, and peer support.

8 weeks
4 virtual group sessions

Follow-up

Participants are monitored for safety and effectiveness after treatment, including completion of outcome measures.

4 weeks

Optional SMP for Control Group

Participants in the control group are offered the SMP after completion of the post-control outcome measures.

8 weeks

Treatment Details

Interventions

  • Virtual Self-Management Program (SMP)
Trial Overview The study is testing a Virtual Self-Management Program (SMP) that includes disease education, self-management strategies, and peer support over eight weeks, compared to standard care without this additional support.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: SMP Program with Standard CareExperimental Treatment1 Intervention
four 60-90 minute virtual educational sessions over 8 weeks with a group of 4-6 participants
Group II: Standard Care OnlyActive Control1 Intervention
Standard of care(no formal education program similar to SMP) and placed on 8-week waitlist for optional intervention.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Calgary

Lead Sponsor

Trials
827
Recruited
902,000+

University of Alberta

Collaborator

Trials
957
Recruited
437,000+

University of Toronto

Collaborator

Trials
739
Recruited
1,125,000+

University of Manitoba

Collaborator

Trials
628
Recruited
209,000+

The Hospital for Sick Children

Collaborator

Trials
724
Recruited
6,969,000+

University of British Columbia

Collaborator

Trials
1,506
Recruited
2,528,000+

Findings from Research

The self-management program (SMP) for adolescents with juvenile idiopathic arthritis (JIA) was found to be acceptable, with participants believing it would effectively support their self-management needs.
Feedback indicated that having a rheumatology health care provider facilitate the sessions would enhance trust in the information provided, and adjustments were made to the program based on participant suggestions to improve its content and format.
Acceptability of an Adolescent Self-Management Program for Juvenile Idiopathic Arthritis.Chomistek, K., Barnabe, C., Naqvi, SF., et al.[2022]
The Internet-based Arthritis Self-Management Program (ASMP) significantly improved health status measures, including pain and disability, in patients with arthritis over a 1-year period, compared to usual care.
Despite the improvements in health status, the program did not lead to significant changes in health behaviors or healthcare utilization, indicating that while it helps with health outcomes, it may not influence how patients engage with their healthcare.
The internet-based arthritis self-management program: a one-year randomized trial for patients with arthritis or fibromyalgia.Lorig, KR., Ritter, PL., Laurent, DD., et al.[2022]
A qualitative study involving 25 participants (9 young people with Juvenile Arthritis, 8 parents or carers, and 8 healthcare professionals) found strong agreement on the need for a mobile app to support self-management of Juvenile Arthritis, emphasizing the importance of ownership and control for young users.
Key features desired for the app include interactive and engaging content, developmentally appropriate information, symptom monitoring, and access to social support, which could enhance the self-management experience for young people with this condition.
Young People's, Parents', and Professionals' Views on Required Components of Mobile Apps to Support Self-Management of Juvenile Arthritis: Qualitative Study.Waite-Jones, JM., Majeed-Ariss, R., Smith, J., et al.[2020]

References

Acceptability of an Adolescent Self-Management Program for Juvenile Idiopathic Arthritis. [2022]
The internet-based arthritis self-management program: a one-year randomized trial for patients with arthritis or fibromyalgia. [2022]
Young People's, Parents', and Professionals' Views on Required Components of Mobile Apps to Support Self-Management of Juvenile Arthritis: Qualitative Study. [2020]
Effectiveness of eHealth and mHealth Interventions Supporting Children and Young People Living With Juvenile Idiopathic Arthritis: Systematic Review and Meta-analysis. [2022]
Teens Taking Charge: A Randomized Controlled Trial of a Web-Based Self-Management Program With Telephone Support for Adolescents With Juvenile Idiopathic Arthritis. [2020]
Multisite Randomized Clinical Trial Evaluating an Online Self-Management Program for Adolescents With Juvenile Idiopathic Arthritis. [2020]
Usability testing of an online self-management program for adolescents with juvenile idiopathic arthritis. [2021]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security